The Use of dSTORM-Based Single Exosome Analysis To Study Tetraspanin Abundance in Extracellular Vesicles
Rattachement africain : us, gb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Serum-derived exosomes are membrane-enclosed nanovesicles secreted by cells, typically between 30 and 120 nm in diameter. Exosomes can be identified by the presence of tetraspanin protein markers including CD9, CD81, and CD63 among others. The relative amounts of these exosomal markers and their location in the exosomes are also related to their source of origin. The ability to investigate these different markers and their locations in individual and multiple exosomes was obtained using an optical imaging technique known as dSTORM (direct stochastic optical reconstruction microscopy) which can overcome the diffraction limit for detection of these nanovesicles. The use of the dSTORM imaging method has allowed us to evaluate the relative abundance of tetraspanin markers CD9, CD81, and CD63 in exosomes and the size of exosomes related to these markers. We also compared the presence of these markers in normal versus pancreatic cancer serum samples and against exosomes secreted from cell lines. We found that CD9 is generally the most abundant marker in exosomes and is found near the surface of the exosomes, although CD81 and CD63 abundance is also significant. This result is consistent with our prior DIA mass spectrometry data and may be important in future work involving analysis of exosomes as markers of disease.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- The Use of dSTORM-Based Single Exosome Analysis To Study Tetraspanin Abundance in Extracellular Vesicles
- Date Crossref
- 29/07/2025
- Éditeur
- American Chemical Society (ACS)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Michigan Department of Surgery pays non établi dans la noticeUniversité ou école supérieure
-
Oxford Nanoimaging (United Kingdom) pays non établi dans la noticeEntreprise
-
Michigan Medicine pays non établi dans la noticeÉtablissement de santé
-
Oxford Nanoimaging Limited pays non établi dans la noticeInstitution
-
Department of Internal Medicine pays non établi dans la noticeInstitution
-
Department of Radiation Oncology pays non établi dans la noticeInstitution
Department of Surgery — University of Michigan, Oxford Nanoimaging (United Kingdom) et Michigan Medicine, avec 3 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.